[Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method]

Area of Science:

• Medical Mycology
• Molecular Biology
• Antimicrobial Resistance

Background:

• Candida albicans is a common opportunistic fungal pathogen.
• Antifungal resistance in C. albicans poses a significant clinical challenge.
• Understanding the genetic basis of antifungal resistance is crucial for effective treatment strategies.

Purpose of the Study:

• To investigate the genotypic characteristics of Candida albicans clinical isolates.
• To determine the relationship between Candida albicans genotypes and their susceptibility to antifungal agents.
• To explore potential genetic correlations with fluconazole resistance.

Main Methods:

• Minimum Inhibitory Concentrations (MICs) were determined using Etest for five antifungal agents.
• Randomly Amplified Polymorphic DNA (RAPD) analysis was employed for genotypic typing of 30 C. albicans isolates.
• Dendrogram analysis was used to correlate RAPD patterns with antifungal resistance profiles.

Main Results:

• Two out of 30 C. albicans isolates exhibited resistance to fluconazole.
• These fluconazole-resistant isolates displayed highly similar Randomly Amplified Polymorphic DNA (RAPD) profiles.
• The study identified a potential genetic correlation between specific RAPD patterns and fluconazole resistance.

Conclusions:

• A significant genetic correlation may exist between fluconazole resistance patterns and RAPD profiles in Candida albicans.
• Genotypic analysis can provide insights into the mechanisms of antifungal resistance.
• Further research is warranted to elucidate the genetic determinants of antifungal resistance in C. albicans.